Drugs / Antareit
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06098742 | Apr → Oct 2024 overdue | active peptic ulcer disease, dyspepsia, upper digestive tract disorder | Valenta Pharm JSC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antareit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06098742 ↗ |
| Route | Oral | “2 sachets of Antareit 800 mg/10 ml oral suspension 2 h prior to food intake” NCT06098742 ↗ |